The California Medical Association Selects The Doctors Company as Its Exclusive Medical Professional Liability Insurance Company Corporate Sponsor
The California Medical Association (CMA), representing nearly 50,000 physicians, has chosen The Doctors Company, part of TDC Group, as its exclusive medical professional liability insurance company (MPLI) corporate sponsor.
Search
Mar 07, 2023
In Memoriam: Donald J. Palmisano, MD, JD, FACS
It is with great sadness that we report the passing of long-time Board Member Donald J. Palmisano, MD, JD, FACS.
From
The Doctor’s Advocate
July 27, 2024, PSQH Podcast
PSQH: The Podcast Episode 109 – The Overwhelming Flood of Patient Wearable Data
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses how data from wearables is affecting physicians and patient care.
Dec 02, 2024
2024 Judicial Review: Significant Court Decisions on Medical Liability Issues
Between fall 2023 and summer 2024, state supreme courts handed down mixed decisions on medical liability issues affecting healthcare professionals.
From
The Doctor’s Advocate
The Importance of Clinical Health Information at the Point of Radiology Order
Having ready access to patients’ clinical information helps radiologists eliminate assumptions and apply their skills and expertise in rendering accurate interpretive reports.
Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
December 30, 2025, Medical Economics
Trends in Medical Malpractice Claims: Social Perception of Health Care Affects Outcomes in the Courtroom
Brittnie Hayes, Esq., Vice President of Claims at The Doctors Company, discusses how shifting public sentiment is driving nuclear verdicts and reshaping malpractice defense.
October 01, 2024, Healthcare Risk Management
Respond Carefully to Notice of Intent
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, shares suggestions for how to properly respond to patients who communicate their intent to sue.
Jun 18, 2024
Industry and Company News Second Quarter 2024
The second quarter 2024 issue includes announcements about a member dividend and the appointment of our new chief operating officer.
From
The Doctor’s Advocate
Jun 05, 2025
The Doctors Company Announces Acquisition of ProAssurance
The Doctors Company has entered into a definitive agreement to acquire ProAssurance, and other company news and insights.
From
The Doctor’s Advocate
